24 June 2024
Sondrel (Holdings) plc
("Sondrel", the "Company" and together with its subsidiaries the "Group")
Suspension of trading on AIM pending publication of 2023 Annual Report & Accounts
Sondrel (AIM: SND), a leading provider of ultra-complex chips for leading global technology brands, provides the following update in relation to its Annual Report and Financial Statements for its financial year ended 31 December 2023 (the "2023 Annual Report").
As stipulated by Rule 19 of the AIM Rules for Companies (the "AIM Rules"), the Company is required to publish its 2023 Annual Report by 30 June 2024. However, the Company confirms that its auditors will require additional time to complete their audit following completion of the Company's subscription to raise £5.6 million on 14 June 2024.
As a result, the Company no longer expects to be able to publish the 2023 Annual Report by 30 June 2024. The Company is now targeting the publication of the 2023 Annual Report during July 2024.
Trading in the Company's ordinary shares on AIM will therefore be suspended with effect from 7.30 a.m. on 1 July 2024 pending publication of the 2023 Annual Report. Suspension from trading is expected to be lifted with the publication of the 2023 Annual Report in due course.
Notwithstanding the anticipated temporary suspension of trading in the Company's ordinary shares, the Company will continue to make announcements as and when there are any developments that require announcement in accordance with its obligations under the AIM Rules.
For further information:
| Sondrel (Holdings) plc | Via Buchanan |
| David Mitchard, Interim CEO | Tel: +44 (0) 20 7466 5000 |
| Nick Stone, Interim CFO | |
| | |
| Cavendish Capital Markets Limited | Tel: +44 (0) 20 7220 0500 |
| Ben Jeynes / Katy Birkin / George Lawson - Corporate Finance | |
| Michael Johnson / Charlie Combe - Sales and ECM | |
|
| |
| Buchanan Communications | Tel: +44 (0) 20 7466 5000 |
Chris Lane / Stephanie Whitmore / Abby Gilchrist sondrel@buchanan.uk.com
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended by virtue of the Market Abuse (Amendment) (EU Exit) Regulation, 2019.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.